TELA Bio (TELA) EBT Margin Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | 4,088.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,088.00 |
| Dec 31, 2025 | 4,603.00 |
| Sep 30, 2025 | 5,268.00 |
| Jun 30, 2025 | 5,838.00 |
| Mar 31, 2025 | 7,012.00 |
| Dec 31, 2024 | 26,813.00 |
| Sep 30, 2024 | 5,162.00 |
| Jun 30, 2024 | 2,986.00 |
| Mar 31, 2024 | 10,472.00 |
| Dec 31, 2023 | 5,485.00 |
| Sep 30, 2023 | 6,957.00 |
| Jun 30, 2023 | 9,207.00 |
| Mar 31, 2023 | 9,305.00 |
| Dec 31, 2022 | 4,663.00 |
| Sep 30, 2022 | 2,542.00 |
| Jun 30, 2022 | 5,050.00 |
| Mar 31, 2022 | 5,361.00 |
| Dec 31, 2021 | 15,564.00 |
| Sep 30, 2021 | 2,174.00 |